Characterization of Intestinal Microbiota Stability in Preterm Born Neonates
- Conditions
- Necrotising EnterocolitisLate-Onset Neonatal Sepsis
- Registration Number
- NCT04792918
- Lead Sponsor
- Emma Marie Caroline Slack
- Brief Summary
Study around very-low birthweight preterm infants at high risk of developing necrotizing enterocolitis (NEC) or late-onset sepsis (LOS). Collection of stool and other biological samples to assess the strain-level stability of gastrointestinal microbiota in these preterm infants who may or may not develop NEC/LOS.
- Detailed Description
This study aims to collect biological samples (stool, stomach fluid, and blood) from preterm infants at risk of developing NEC or LOS; as well as environmental samples from infants' hospital surroundings (swabs, air), nutritional intake (formula, breastmilk) and samples from their family members (faeces, vaginal swab).
The main focus of the study is to assess strain-level stability of gastrointestinal microbiota in these infants and potentially assess the source of disease-causing microbiota species/strains.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 81
-Preterm infants with a gestational age < 32 weeks or a birthweight < 1500g and their family members
- Intestinal atresia
- Live born infants referred to from other hospitals later than 3 days after birth
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Strain-level stability 24 months Identify members of the gastrointestinal microbiota (species/strains) that are associated with development of NEC or LOS in very-low birthweight/very preterm Identify members of the gastrointestinal microbiota (species/strains) that are associated with development of NEC or LOS in very-low birthweight/very preterm infants via changes in frequencies, absolute colonization levels, or temporal stability
- Secondary Outcome Measures
Name Time Method Source of bacterial species/strains 24 months Quantify genetic similarity between potentially disease-causing microbiota strains found within NEC/LOS patients and within family members (faeces, breastmilk, vaginal swab) and hospital surroundings
Trial Locations
- Locations (2)
University Hospital Zürich
🇨🇭Zürich, Switzerland
University Children's Hospital Zürich
🇨🇭Zürich, Switzerland